NEW YORK, NY / ACCESSWIRE / July 16, 2015 / MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) today published a new blog post on The Chairman’s Blog, written by the Company’s Chief Executive Officer, David Hansen. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

In his new post, Mr. Hansen highlights the unique nature of MabVax’s antibody discovery platform, commenting, “[MabVax is] the only company in the world that really does find fully human antibodies in the full sense of the term.” Hansen writes that the Company’s highly directive discovery process, along with the antibodies’ low risk of serious side effects, opens MabVax up to a myriad of partnership opportunities in the future. Read the full blog post from Mr. Hansen on TheChairmansBlog.com (http://www.thechairmansblog.com/mabvax-therapeutics/david-hansen/when-is-a-fully-human-antibody-really-fully-human/).

About MabVax Therapeutics

MabVax Therapeutics Holdings, Inc. is a clinical stage oncology drug development company focused on the development of human antibody-based products and vaccines to address unmet medical needs in the treatment of cancer. MabVax has discovered a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been immunized against targeted cancers with the Company’s proprietary vaccines. MabVax is preparing to enter two Phase 1 clinical trials of HuMab 5B1 – one for the diagnosis, and the other for the treatment, of metastatic pancreatic cancer in late 2015. MabVax has the exclusive license to therapeutic vaccines from Memorial Sloan Kettering Cancer Center. MabVax has two cancer vaccines targeting recurrent sarcoma and ovarian cancer in proof of concept Phase II multi-center clinical trials, and a vaccine targeting neuroblastoma that will be ready for Phase II clinical trial later this year. Additional information about the Company is available at www.mabvax.com.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

SOURCE: TheChairmansBlog.com

ReleaseID: 430620

The Award Recognizes the Company as “The Elite of the Elite”

DALLAS, TX / ACCESSWIRE / July 16, 2015 / Roof repair experts Aspenmark Roofing & Solar of Dallas, Texas has received GAF’s most prestigious contractor award: The GAF President’s Club Award. This highly coveted award recognizes Aspenmark Roofing & Solar as one of the “elite of the elite” residential roofing contractors in the United States.

GAF is North America’s largest roofing manufacturer, and only GAF Master Elite (R) Contractors can compete for its President’s Club Award. To qualify for this award, a contractor must demonstrate an exceptional level of excellence in their business, especially in the areas of Installation Excellence, Consumer Protection, and Installer Training.

Aspenmark Roofing & Solar, which provides top-notch roof maintenance and replacement in Dallas, TX, has been a GAF Master Elite Contractor since 2009. To become a Master Elite Contractor-a status that less than 2 percent of roofing contractors nationwide have achieved-a candidate must demonstrate proper licensing and adequate insurance, have a proven reputation and show commitment to ongoing professional training.

What do people call a contractor who is always striving to say “yes” to customers, has founded its own roofing charity to give back to the communities it serves, and produces wines through its own Napa Valley vineyard? Some may use the term customer-centric, others may say innovative, while others simply call it Aspenmark Roofing & Solar.

“We’re one of the good guys,” says Chris Zazo, Chief Executive Officer. “In an industry where good service is hard to find, we deliver everything in a positive fashion to find what’s best for the customer. We make our homeowners and commercial building owners feel like part of the Aspenmark family.”

The company is dedicated to providing “white-glove” service for its leaky roof repair and other services. “Our trucks are clean,” states Zazo. “Our people follow a dress code. Trucks and shirts alike display our logo. When we’re on the job, we’re taking care of and in custody of someone’s home—so we ensure that we give customers the respect they deserve. We pride ourselves on that reputation.”

Aspenmark utilizes modern technology in all aspects of its daily work. “We give our presentations on iPads, and we have access to all the technical information on the GAF side. Our pricing is readily available, so we have a real-time quoting model. On top of all this, we employ an expert social-media strategy that delivers on-going value to our customers. Homeowners can find great roofing resources on our Facebook, Twitter, and LinkedIn pages, which are proving to be great ways to interact with customers,” Zazo adds. The company also utilizes cutting-edge weather technology through the National Storm Damage Center, a contractor network that shares information and job leads outside of contractors’ home markets.

In partnership with Dallas Habitat for Humanity, Aspenmark has founded its own charity, called Roof Angels, says Zazo. “We provide roofing for veterans, for people without insurance, or anyone who can’t afford it, really. It’s been a big hit since we launched last year. The charity work has also helped engage our employees through service to others, which ultimately reinforces our overall approach to doing business, so it’s really had a ripple effect throughout our company. Studies have shown that this type of program increases employee retention. It helps with morale and keeping people together.” Aspenmark also plans to roof 40 homes for Habitat for Humanity in 2015.

And regarding the wine? “That’s on the fun side,” says Zazo. “Because so much of our living comes from repairing hail damage, we named our winery Hailstone Vineyards. Its quality Napa wine, and we’re very proud of it. It started as a customer appreciation thing, but now it’s got some distribution throughout the country and is even served at some high-end restaurants. It’s actually another sign of how we do things at Aspenmark: first-rate and with class.”

Looking toward the future, Zazo concludes: “We’re on a path of continuing to grow and build on our reputation and credentials, aided in large part by our great partners and distributors. Working as a network and a family, they really make us look like stars.”

About Aspenmark Roofing & Solar:

Serving the Dallas/Fort Worth area since 2005, Aspenmark’s core business values are designed to provide an exceptional experience, by delivering quality workmanship and unmatched value- before, during, and after the job, while offering the safest and cleanest job sites in the industry. For more information, please visit http://www.aspenmarkroofing.com/home

About GAF:

Founded in 1886, GAF has become the largest roofing manufacturer in North America. The company’s products include a comprehensive portfolio of steep-slope and commercial roofing systems, which are supported by an extensive national network of factory-certified contractors. Its success is driven by its commitment to Advanced Quality, Industry Expertise, and Solutions Made Simple for contractors, specifiers, and property owners alike. In 2011, GAF was the first roofing manufacturer to offer a Lifetime limited warranty on all of its laminated shingles and, in 2012, it introduced the GAF Lifetime Roofing System. For more about GAF, visit http://www.gaf.com.

Contact:

Zachary Hamilton
admin@rocketfactor.com
(949) 555-2861

SOURCE: Aspenmark Roofing & Solar

ReleaseID: 430630

SALT LAKE CITY, UT / ACCESSWIRE / July 16, 2015 / Having already achieved widespread success with its unique business model of luxury dining combined with several different forms of live entertainment, Latitude 360 (OTCQB:LATX) recently expanded its growing portfolio with the acquisition of Major League Fantasy, a leader in the world of daily fantasy sports, a market that has exploded in popularity in recent years.

Last year over 57. million Americans played fantasy sports, and by the end of 2016 it is estimated that fantasy sports will make up a 6 to 10 billion dollar industry, with daily fantasy games accounting for a growing stake in those figures. With this move, Latitude 360, which currently trades at $.52 cents per share, will enter into the multi-billion dollar industry of fantasy sports, boasting its own proprietary live fantasy game to take place in its restaurants, called “360 Fantasy Live.” At $8.5 million in cash and stock, the deal is viewed as a favorable one for the company, as MLF had recently tripled in size and popularity just as the daily fantasy sports market is booming.

The acquisition of MLF allows Latitude 360 to position itself as one of the first live, multimedia venues to offer in-house, high-stakes, competitive daily fantasy events. The “360 Fantasy Live” experience coincides with a major move by daily fantasy juggernaut DraftKings to partner with Los Angeles sports mega-plex the Staples Center to create a DraftKings bar and lounge where fantasy players can engage in the latest DraftKings games.

With the success of DraftKings and its rival, FanDuel, Yahoo (YHOO) recently decided the time was right to join the daily fantasy fray, launching its first ever daily format. While the company has long been one of the leaders in seasonal fantasy sports, their first entry into daily gaming marks an industry boom reflected in recent numbers that indicate over 55 million North Americans have engaged in fantasy sports this year alone. Right at the apex of this market explosion, LATX will offer one of the most original daily fantasy experiences available to consumers. It is the latest in a series of moves made by the company that are intended to gradually branch into new markets.

About this latest move, CEO of Major Leage Fantasy, Jesse Merl, who will transition into the role of President of “360 Fantasy Live,” said: “Together with Latitude, we are creating a new way to play. We are confident that along with the ability to interact socially through our product, the ability to join in the energy of a live group viewing experience is going to be a differentiator that matters when people decide where to be during big games.”

Indeed, the “big games” will be taking place not only on Latitude 360’s TV screens, but also in its “VIP Rooms,” where the entry fee alone for its Fantasy Live games will max out at $25,000. The company expects its patrons to partake in its high-stakes fantasy games while enjoying all of the amenities of the standard “360 Experience,” which includes a comedy club, cigar lounge, entertainment theater, bowling lanes, and more.

Amid the high-profile MLF acquisition, Latitude 360 is also focused on the overall expansion of its brick and mortar locations, as several new 360 venues will soon pop up in major cities like Boston, Atlantic City, and Chicago. While the size of each venue typically falls within the 60,000-80,000 square-foot range, the company is also planning a mammoth grand opening of a 100,000 square-foot location at the center of New York’s financial district in Wall Street.

Latitude 360’s existing customer base should blend seamlessly with its target daily fantasy audience, as fantasy players tend to profile as middle to upper-class males from 18 to 49 years of age. By focusing on the young professional demographic in key cities, Latitude 360’s “something-for-everyone” approach, aims to attract these consumers and more, as those uninterested in high-stakes fantasy games can also just relax and eat a delicious meal or visit the cigar lounge.

Latitude 360 remains a focused, driven company with several key components in place that are designed to build a loyal customer base, such as its “360 Club” membership program. “360 Fantasy Live” should prove to be yet another such endeavor for the company, as these events offer a unique, live daily fantasy gaming experience unrivaled at any other establishments. With its venture into fantasy sports, LATX once again demonstrates that it is a company to watch closely for investors in upscale dining. Most importantly, this venture could prove to be an even bigger winner outside the venue four walls for LATX as well.

DISCLAIMER:

Seraphim Strategies is a third party publisher. Not a registered broker/dealer/analyst/adviser, holds no investment licenses and may not sell, offer to sell or offer to buy any security. Market updates, news alerts and corporate profiles are not a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is not to be interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. For full disclaimer please read http://tomorrowsbluechips.com/disclaimer/ This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

“Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,” “future,” “plan” or “planned,” “will” or “should,” “expected,” “anticipates,” “draft,” “eventually,” or “projected.” You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

SOURCE: Seraphim Strategies

ReleaseID: 430614

NAPANEE, ON / ACCESSWIRE / July 16, 2015 / On July 10, 2015 ABcann Medicinals received its full facility approval from Health Canada. Through this approval, ABcann will now be able to flower the plants they currently have growing and put it through the necessary testing prior to sale.

“Full room approval has been provided and dictates that all bloom rooms, growth chambers, vegetation room, clean/general horticulture rooms, processing and drying areas, as well as ABcann’s in house laboratory, have been given Health Canada’s blessing to commence full production activities,” says Tim Humberstone, Senior Person In-Charge at ABcann.

ABcann has been preparing for this approval for many months and is very excited to be able to grow in every room at the facility. ABcann’s production cycle began in January 2015 with the planting of the first set of seeds and has been waiting since to further the growth process for their overall goal of standardization. When asked about ABcann’s process with Health Canada so far, Tim Humberstone stated, “Recent communications and discussions with Health Canada has provided extremely positive feedback from our partners and we strongly feel that our path to provide standardized medicine was the right choice.”

ABcann expects to sell a combination of High THC, High CBD and Blended THC and CBD strains that will be subject to rigorous third-party testing. Once internal and external testing has been completed, specific values of THC and CBD genetics will be available. Through this process, each ABcann strain will be certified by Tru-ID, a company that authenticates food and natural health products. Tru-ID has entered into an exclusive partnership with ABcann to authenticate medical cannabis. “Once our products are tested and the results approved by Health Canada, ABcann Medicinals Inc. expect to be providing clients with our medical cannabis in the very near future,” says Humberstone on product availability.

This room approval came in the midst of a defining moment for medical cannabis in Canada. On July 8, 2015 Health Canada issued a statement that issued a Section 56 exemption under the Controlled Drugs and Substances Act (CDSA) allowing licensed producers to produce and sell cannabis oil and fresh cannabis. ABcann is in the process of applying to develop cannabis oil to allow for patients choice in their medical cannabis. The cannabis oil produced at ABcann will also undergo the same testing procedures as dried cannabis and will carry the same certifications to ensure standardization of the product.

ABcann is currently working on determining which strains and THC/ CBD levels will be available in the cannabis oil. For more updates on product availability and registration dates, please visit www.abcann.ca

About ABcann Medicinals Inc.

ABcann Medicinals Inc. is an approved Licensed Producer under the Marihuana for Medical Purposes Regulations (MMPR). We believe the success of the pharmaceutical industry was based on their ability to manufacture medicine achieved through methods of precision, quality controls, high standards and good manufacturing practices. ABcann has structured our vision to align with these principles. We’ve developed a system capable of producing standardized chemical compounds derived from plants. This unique technology sets us apart from the traditional competitors in the cannabis industry. Experts agree this is the only way to grow plants to be accepted as medicine.

Professor Raphael Mechoulam states:

“Your effort to have Cannabis crops fully standardized from batch to batch moves Cannabis treatment closer to the drug standards generally accepted by physicians and patients and represents an important and very valuable step.”

www.ABcann.ca
www.twitter.com/abcannmed
www.linkedin.com/abcannmed

For Media Inquires Contact:

info@abcann.ca
1-855-322-2266

SOURCE: ABcann Medicinals Inc.

ReleaseID: 430617

TORONTO, ON / ACCESSWIRE / July 16, 2015 / Abba Medix Group Inc. (CSE: ABA) (“Abba” or the “Company”), has entered into an advisory services agreement with Jacob Securities Inc. (“JSI”) pursuant to which JSI continues to provide Abba various strategic and advisory services including advice related to maximizing and realizing the value of Abba and its assets, general management and strategic advice related to Abba’s ongoing operations among other services.

In consideration for acting as strategic advisor, JSI was issued 1,000,000 common Company shares at a price of $0.40 per share, representing the closing price of the Company’s common shares on the Canadian Securities Exchange on July 2, 2015, by way of a debt settlement private placement pursuant to Section 2 of Policy 6 of the Canadian Securities Exchange.

“We’re very excited to be working with Abba Medix,” said Sasha Jacob, JSI CEO, “With the recent Health Canada announcement allowing medical marijuana licensees to provide a larger selection of cannabis products to Canadians we see the medical marijuana market expanding and maturing.” Abba, with the pending acquisitions of RedeCan Pharm and Blow Vapor, along with its own MMPR application, will be in a unique position to service Canadian medical marijuana users quickly and efficiently.

“Jacob Securities has been at the cutting edge of the Canadian Medical Marijuana market since it was first created,” Ray Rasouli, Abba President and CEO, stated. “Jacob brings a wealth of experience as well as a broad range of contacts in the industry. We appreciate the insights and acumen Jacob continues to bring to Abba.”

The Company would also like to clarify various statements from its press release dated July 10, 2015. In that press release, the Company incorrectly referred to Blow Vapor as a subsidiary of Abba Medix Group Inc. As was announced on April 20, 2015, while Abba and Blow Vapor have entered into a memorandum of understanding, as amended, Abba and Blow Vapor have not entered into a definitive purchase agreement with respect to the transaction and Abba has not completed the acquisition of Blow Vapor. No assurance can be given that a definitive purchase agreement will be entered into or that this acquisition will be completed.

‎Abba Medix Group Inc. remains committed to the completion of the acquisition of Blow Vapor. Abba will issue a press release with respect to the acquisition of Blow Vapor as required by applicable securities laws and the rules of CSE.

About Abba Medix Group

Abba Medix Group Inc. (CSE: ABA) is a purveyor of fine Canadian medical marijuana, accessories, events and news. The Company intends to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully-integrated, Canadian medical marijuana marketplace. Abba’s mission is to find and acquire strong marijuana related businesses, product companies, organizational event sponsorships, and research and development opportunities.

Upon completion of its acquisition of RedeCan, Abba will be a licensed medical marijuana grower and sales agent, authorized to supply Canadian patients.

For more information on Abba Medix Group Inc., please visit www.abbamedix.com. For more information on RedeCan, visit http://redecanpharm.ca and on Blow Vapor, visit www.blowvapor.com.

About Jacob Securities

Jacob Securities is Canada’s leading independent investment dealer focused on renewable energy, clean technology and the medical marijuana sector. Based in Toronto, JSI has completed more transactions in the renewable energy and medical marijuana sectors than any other investment dealer in Canada. JSI has participated in transactions valued in excess of $7 billion for renewable power projects since 2006 and raised over $70 million for public and private cannabis companies since 2014. For more information please visit www.jacobsecurities.com.

Cautionary Statements Regarding Forward-Looking Information

Certain statements within this press release relating to the Company constitute “forward-looking statements, “within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and / or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are “forward-looking statements.” Such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including production and / or sales of medical marijuana, quantities of future medical marijuana production, anticipated revenues in connection with such sales, the overall projected size of the market, completion and / or expansion of production facilities, and other information that is based on forecasts of future results, estimates of production not yet determinable, and other key management assumptions. Actual results may differ materially from those expressed or implied by such forward-looking statements and involve risk and uncertainties relating to the Company’s historical experience with regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in medical marijuana prices, actual operating performance of facilities, and other uninsured risks. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For further information please contact:

Ahmad (Ray) Rasouli
Chief Executive Officer
Abba Medix Group Inc.
Tel: (905) 492-9420

SOURCE: Abba Medix Group Inc.

ReleaseID: 430633